Department of Radiation Oncology, Imaging Division, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Support Care Cancer. 2022 Nov;30(11):9527-9538. doi: 10.1007/s00520-022-07322-w. Epub 2022 Aug 30.
Head and neck cancer (HNC) and its treatment often negatively impact swallowing function. The aim was to investigate the course of patient-reported swallowing problems from diagnosis to 3, 6, 12, and 24 months after treatment, in relation to demographic, clinical, and lifestyle factors.
Data were used of the Netherlands Quality of Life and Biomedical Cohort Study in head and neck cancer research (NET-QUBIC). The primary outcome measures were the subscales of the Swallowing Quality of Life Questionnaire (SWAL-QOL). Linear mixed-effects models (LMM) were conducted to investigate changes over time and associations with patient, clinical, and lifestyle parameters as assessed at baseline.
Data were available of 603 patients. There was a significant change over time on all subscales. Before treatment, 53% of patients reported swallowing problems. This number increased to 70% at M3 and decreased to 59% at M6, 50% at M12, and 48% at M24. Swallowing problems (i.e., longer eating duration) were more pronounced in the case of female, current smoking, weight loss prior to treatment, and stage III or IV tumor, and were more prevalent at 3 to 6 months after treatment. Especially patients with an oropharynx and oral cavity tumor, and patients receiving (C)RT following surgery or CRT only showed a longer eating duration after treatment, which did not return to baseline levels.
Half of the patients with HNC report swallowing problems before treatment. Eating duration was associated with sex, smoking, weight loss, tumor site and stage, and treatment modality, and was more pronounced 3 to 6 months after treatment.
头颈部癌症(HNC)及其治疗常对吞咽功能产生负面影响。本研究旨在探讨患者从诊断到治疗后 3、6、12 和 24 个月报告的吞咽问题的过程,分析与人口统计学、临床和生活方式因素的关系。
本研究使用了荷兰头颈部癌症质量与生物医学队列研究(NET-QUBIC)的数据。主要结局指标为吞咽生活质量问卷(SWAL-QOL)的子量表。采用线性混合效应模型(LMM)来研究随时间的变化以及与患者、临床和生活方式参数的相关性,这些参数是在基线时评估的。
本研究共纳入 603 名患者。所有子量表在治疗期间均有显著变化。治疗前,53%的患者报告存在吞咽问题。在 M3 时这一比例增加到 70%,在 M6 时下降至 59%,在 M12 时下降至 50%,在 M24 时下降至 48%。女性、当前吸烟、治疗前体重减轻、肿瘤分期为 III 或 IV 期的患者吞咽问题(即更长的进食时间)更为明显,且在治疗后 3 至 6 个月时更为普遍。特别是口咽和口腔肿瘤患者,以及接受手术加(C)RT 或单纯 CRT 治疗的患者,在治疗后进食时间更长,且未恢复到基线水平。
一半的头颈部癌症患者在治疗前报告存在吞咽问题。进食时间与性别、吸烟、体重减轻、肿瘤部位和分期以及治疗方式有关,且在治疗后 3 至 6 个月时更为明显。